• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰十二指肠切除术治疗远端胆管癌时手术切缘状态对生存和复发的影响:显微镜下残留肿瘤(R1)是否与更高的局部复发率相关?

Impact of Surgical Margin Status on Survival and Recurrence After Pancreaticoduodenectomy for Distal Cholangiocarcinoma: Is Microscopic Residual Tumor (R1) Associated with Higher Rates of Local Recurrence?

机构信息

Department of Hepatobiliary and Pancreatic Surgery, National Cancer Center Hospital, Tokyo, Japan.

Department of Molecular Pathology, National Cancer Center Hospital, Tokyo, Japan.

出版信息

Ann Surg Oncol. 2024 Aug;31(8):4910-4921. doi: 10.1245/s10434-024-15313-w. Epub 2024 Apr 28.

DOI:10.1245/s10434-024-15313-w
PMID:38679686
Abstract

BACKGROUND

Patients undergoing macroscopically curative resection for distal cholangiocarcinoma (DCC) have high recurrence rates and poor prognoses. This study aimed to investigate the impact of surgical margin status on survival and recurrence after resection of DCC, specifically focusing on microscopic residual tumor (R1) and its relationship to local recurrence.

PATIENTS AND METHODS

This was a retrospective analysis of patients who had undergone pancreaticoduodenectomy (PD) for DCC between 2005 and 2021. Surgical margin was classified as R0, R1cis (positive bile duct margin with carcinoma in situ), and R1inv (positive bile duct margin with an invasive subepithelial component and/or positive radial margin).

RESULTS

In total, 29 of 133 patients (21.8%) had R1cis and 23 (17.3%) R1inv. The 5-year overall survival (OS) for R0 (55.7%) did not differ significantly from that for R1cis/R1inv (47.4%/33.6%, respectively). The 5-year recurrence-free survival (RFS) for R0 was significantly longer than that for R1inv (50.1% vs. 17.4%, p = 0.003), whereas RFS did not differ significantly between those with R0 and R1cis. R1cis/R1inv status was not an independent predictor of OS and RFS in multivariate analysis. Cumulative incidence of isolated distant recurrence was significantly higher for R1cis/R1inv than for R0 (p = 0.0343/p = 0.0226, respectively), whereas surgical margin status was not significantly associated with rates of local or local plus distant recurrence.

CONCLUSIONS

Surgical margin status does not significantly impact OS and RFS in patients undergoing PD for DCC following precise preoperative imaging evaluation. Additionally, R1 status is significantly linked to higher isolated distant recurrence rather than local recurrence, highlighting the importance of multidisciplinary therapy.

摘要

背景

接受远端胆管癌(DCC)根治性切除术的患者复发率和预后较差。本研究旨在探讨手术切缘状态对 DCC 切除后生存和复发的影响,特别是关注显微镜下残留肿瘤(R1)及其与局部复发的关系。

患者和方法

这是一项对 2005 年至 2021 年间接受胰十二指肠切除术(PD)治疗 DCC 的患者进行的回顾性分析。手术切缘分为 R0、R1cis(阳性胆管切缘伴原位癌)和 R1inv(阳性胆管切缘伴上皮下侵袭性成分和/或阳性放射状切缘)。

结果

共有 133 例患者中的 29 例(21.8%)为 R1cis,23 例(17.3%)为 R1inv。R0 组(55.7%)的 5 年总生存率(OS)与 R1cis/R1inv 组(分别为 47.4%/33.6%)无显著差异。R0 组的 5 年无复发生存率(RFS)明显长于 R1inv 组(50.1%比 17.4%,p=0.003),而 R0 与 R1cis 组之间的 RFS 无显著差异。多因素分析显示,R1cis/R1inv 状态不是 OS 和 RFS 的独立预测因素。孤立远处复发的累积发生率 R1cis/R1inv 明显高于 R0(p=0.0343/p=0.0226),而手术切缘状态与局部或局部加远处复发率无显著相关性。

结论

经过精确的术前影像学评估,PD 治疗 DCC 后,手术切缘状态对患者的 OS 和 RFS 无显著影响。此外,R1 状态与较高的孤立远处复发率显著相关,而与局部复发率无关,这突出了多学科治疗的重要性。

相似文献

1
Impact of Surgical Margin Status on Survival and Recurrence After Pancreaticoduodenectomy for Distal Cholangiocarcinoma: Is Microscopic Residual Tumor (R1) Associated with Higher Rates of Local Recurrence?胰十二指肠切除术治疗远端胆管癌时手术切缘状态对生存和复发的影响:显微镜下残留肿瘤(R1)是否与更高的局部复发率相关?
Ann Surg Oncol. 2024 Aug;31(8):4910-4921. doi: 10.1245/s10434-024-15313-w. Epub 2024 Apr 28.
2
Residual Carcinoma In Situ at the Ductal Stump has a Negative Survival Effect: An Analysis of Early-stage Cholangiocarcinomas.胆管残端原位癌具有负面生存影响:早期胆管癌分析
Ann Surg. 2017 Jul;266(1):126-132. doi: 10.1097/SLA.0000000000001944.
3
Residual biliary intraepithelial neoplasia without malignant transformation at resection margin for perihilar cholangiocarcinoma does not require expanded resection: a dual center retrospective study.肝门周围胆管癌切缘残留无恶性转化的胆管上皮内瘤变不需要扩大切除:一项双中心回顾性研究。
World J Surg Oncol. 2024 Jun 21;22(1):161. doi: 10.1186/s12957-024-03395-5.
4
Adjuvant concurrent chemoradiation therapy in patients with microscopic residual tumor after curative resection for extrahepatic cholangiocarcinoma.根治性切除术后有镜下残余肿瘤的肝外胆管癌患者的辅助同步放化疗。
Clin Transl Oncol. 2018 Aug;20(8):1011-1017. doi: 10.1007/s12094-017-1815-y. Epub 2017 Dec 18.
5
Association of Perioperative Transfusion with Recurrence and Survival After Resection of Distal Cholangiocarcinoma: A 10-Institution Study from the US Extrahepatic Biliary Malignancy Consortium.围手术期输血与远端胆管癌切除术后复发和生存的关系:来自美国肝外胆管恶性肿瘤联盟的 10 个机构研究。
Ann Surg Oncol. 2019 Jun;26(6):1814-1823. doi: 10.1245/s10434-019-07306-x. Epub 2019 Mar 15.
6
High-grade dysplasia/carcinoma in situ of the bile duct margin in patients with surgically resected node-negative perihilar cholangiocarcinoma is associated with poor survival: a retrospective study.手术切除淋巴结阴性肝门周围胆管癌患者胆管边缘高级别发育不良/原位癌与生存不良相关:一项回顾性研究。
J Hepatobiliary Pancreat Sci. 2017 Aug;24(8):456-465. doi: 10.1002/jhbp.481. Epub 2017 Jul 3.
7
Significance of ductal margin status in patients undergoing surgical resection for extrahepatic cholangiocarcinoma.肝外胆管癌手术切除患者胆管切缘状态的意义
World J Surg. 2007 Sep;31(9):1788-1796. doi: 10.1007/s00268-007-9102-7. Epub 2007 Jul 25.
8
Intraoperative frozen section diagnosis of bile duct margin for extrahepatic cholangiocarcinoma.肝外胆管癌胆管切缘的术中冰冻切片诊断。
World J Gastroenterol. 2018 Mar 28;24(12):1332-1342. doi: 10.3748/wjg.v24.i12.1332.
9
Impact of ductal resection margin status on long-term survival in patients undergoing resection for extrahepatic cholangiocarcinoma.肝外胆管癌切除术患者中,胆管切缘状态对长期生存的影响。
Cancer. 2005 Mar 15;103(6):1210-6. doi: 10.1002/cncr.20906.
10
Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma.肝切除切缘对肝内胆管癌复发和生存的影响。
Ann Surg Oncol. 2008 Oct;15(10):2787-94. doi: 10.1245/s10434-008-0081-1. Epub 2008 Aug 7.

引用本文的文献

1
Impact of Resection Margins and Adjuvant Therapy on Survival Outcomes in Lymph Node-Negative Distal Cholangiocarcinoma.切缘及辅助治疗对淋巴结阴性远端胆管癌生存结局的影响
Curr Oncol. 2025 Mar 19;32(3):178. doi: 10.3390/curroncol32030178.

本文引用的文献

1
A Multicenter Survey on Eligibility for a Randomized Phase III Trial of Adjuvant Chemotherapy for Resected Biliary Tract Cancer (JCOG1202, ASCOT).一项关于可切除胆管癌辅助化疗随机III期试验(JCOG1202,ASCOT)入选资格的多中心调查。
Ann Surg Oncol. 2023 Nov;30(12):7331-7337. doi: 10.1245/s10434-023-13913-6. Epub 2023 Jul 14.
2
Prognostic Impact of Margin Status in Distal Cholangiocarcinoma.切缘状态对远端胆管癌的预后影响
World J Surg. 2023 Apr;47(4):1034-1041. doi: 10.1007/s00268-023-06889-7. Epub 2023 Feb 3.
3
Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial.
辅助 S-1 对比观察用于可切除胆管癌(JCOG1202,ASCOT):一项多中心、开放标签、随机、对照、III 期临床试验。
Lancet. 2023 Jan 21;401(10372):195-203. doi: 10.1016/S0140-6736(22)02038-4.
4
Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial.可切除和边缘可切除胰腺癌的新辅助放化疗与 upfront 手术比较:荷兰随机 PREOPANC 试验的长期结果。
J Clin Oncol. 2022 Apr 10;40(11):1220-1230. doi: 10.1200/JCO.21.02233. Epub 2022 Jan 27.
5
The Impact of Intraoperative Frozen Section on Resection Margin Status and Survival of Patients Underwent Pancreatoduodenectomy for Distal Cholangiocarcinoma.术中冰冻切片对远端胆管癌胰十二指肠切除术患者切缘状态及生存的影响
Front Oncol. 2021 May 3;11:650585. doi: 10.3389/fonc.2021.650585. eCollection 2021.
6
Impact of Remnant Carcinoma in Situ at the Ductal Stump on Long-Term Outcomes in Patients with Distal Cholangiocarcinoma.胆管残端原位癌对远端胆管癌患者长期预后的影响。
World J Surg. 2021 Jan;45(1):291-301. doi: 10.1007/s00268-020-05799-2. Epub 2020 Sep 28.
7
Cholangiocarcinoma 2020: the next horizon in mechanisms and management.胆管癌 2020:机制和管理的新前沿。
Nat Rev Gastroenterol Hepatol. 2020 Sep;17(9):557-588. doi: 10.1038/s41575-020-0310-z. Epub 2020 Jun 30.
8
Neoadjuvant chemotherapy with gemcitabine plus cisplatin followed by radical liver resection versus immediate radical liver resection alone with or without adjuvant chemotherapy in incidentally detected gallbladder carcinoma after simple cholecystectomy or in front of radical resection of BTC (ICC/ECC) - a phase III study of the German registry of incidental gallbladder carcinoma platform (GR)- the AIO/ CALGP/ ACO- GAIN-trial.新辅助化疗联合吉西他滨和顺铂后根治性肝切除术与单纯胆囊切除术后或根治性 BTC 切除术前单纯根治性肝切除术或辅助化疗与或不辅助化疗在偶然发现的胆囊癌中的比较(ICC/ECC) - 德国偶然发现的胆囊癌平台(GR)登记处的 III 期研究- AIO/CALGP/ACO-GAIN 试验。
BMC Cancer. 2020 Feb 14;20(1):122. doi: 10.1186/s12885-020-6610-4.
9
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study.卡培他滨对比观察用于可切除胆管癌(BILCAP):一项随机、对照、多中心、3 期研究。
Lancet Oncol. 2019 May;20(5):663-673. doi: 10.1016/S1470-2045(18)30915-X. Epub 2019 Mar 25.
10
Prognostic comparison of the longitudinal margin status in distal bile duct cancer: R0 on first bile duct resection versus R0 after additional resection.远端胆管癌纵向切缘状态的预后比较:首次胆管切除时达到 R0 与追加切除后达到 R0 相比。
J Hepatobiliary Pancreat Sci. 2019 May;26(5):169-178. doi: 10.1002/jhbp.619. Epub 2019 Apr 8.